Canopy Growth Corporation (CGC) to Report Q2 2022 Financial Results on November 5, 2021
Marijuana Industry NewsUncategorized October 22, 2021
Canopy Growth to Report Q2 2022 Financial Results on November 5, 2021…
The post Canopy Growth Corporation (CGC) to Report Q2 2022 Financial Results on November 5, 2021 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read moreJushi Holdings Inc. (JUSHF) Opens its 25th Retail Location Nationwide
Uncategorized October 22, 2021
Jushi Holdings Inc. Opens its 25th Retail Location Nationwide, 16th BEYOND /…
The post Jushi Holdings Inc. (JUSHF) Opens its 25th Retail Location Nationwide appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read moreFirst Patient Dosed in Phase IIa DMT-Assisted Therapy Clinical Trial
Marijuana Stocks, Finance, & InvestingUncategorized October 21, 2021
Small Pharma commences enrolling patients for its Phase IIa DMT-based clinical trial aimed at treating Major Depressive Disorder.
Read moreField Trip Health Ltd. Continues Expansion With Psychedelic-Assisted Therapy Centers in Seattle, Vancouver and Fredericton
Marijuana Stocks, Finance, & InvestingUncategorized October 21, 2021
Field Trip is adding three new clinics to its network, with two of the three already open and the third opening imminently.
Read moreCOMPASS Pathways is granted new US patent for crystalline psilocybin
Marijuana Stocks, Finance, & InvestingUncategorized October 21, 2021
Compass Pathway’s fourth U.S. patent covers its Form A hydrate psilocybin, and is the first patent for this formulation.
Read morePsychedelics Industry Moving Full-Speed Ahead, When Will Stocks Catch Up?
Marijuana Stocks, Finance, & InvestingUncategorized October 21, 2021
Cash-rich psychedelic stocks are cheap. They are also building value for investors — at an accelerating rate.
Read moreSmall Pharma Granted Fast-Track Designation From U.K. Regulator for DMT-Assisted Therapy for Major Depressive Disorder
Marijuana Stocks, Finance, & InvestingUncategorized October 21, 2021
The UK drug regulator (MHRS) has granted Small Pharma Fast-Track Designation with respect to SPL026 for Major Depressive Disorder (MDD).
Read moreCannabis Transactions: Over-Negotiation is a Problem
Uncategorized October 21, 2021
There are a lot of reasons why deals may stall or fall apart before the parties can ever sign a contract. Maybe a deal is too complicated. Maybe the parties can’t come to an agreement on the major terms. Maybe it’s not legally practical. But one thing our cannabis business lawyers have seen time and
The post Cannabis Transactions: Over-Negotiation is a Problem appeared first on Harris Bricken.
Read more